A coalition of 12 Philadelphia-area health systems announced Monday that its members have abandoned the use of race adjustments in four clinical tools commonly used to guide care, a move that health leaders say will improve treatment and prevent delays in diagnosis for Black, Hispanic, and Asian patients. The decision marks one of the largest and broadest efforts to date to remove race from widely used clinical algorithms.
The FDA’s Suzanne Schwartz said at The Medtech Conference that addressing legacy devices is a “work in progress” and a problem regulators and industry need to work on together.
Lawmakers on both sides of the aisle in the House and Senate are calling for COVID-era flexibilities on telemedicine services to be extended to ensure access to “necessary and life-saving treatments,” and are speaking out against a proposed rule reportedly being advanced by the DEA that would limit telemedicine prescribing.
In a rare head-to-head analysis, Yale's health system evaluated the statistical performance of six early warning scores on the same clinical data from seven of its hospitals, publishing its results Tuesday in JAMA Network Open. It revealed that some clinical AI models aren't all they're cracked up to be.
A nonprofit biotechnology company based in Philadelphia has received $60 million from a TED initiative that funds "big ideas." The company, Every Cure, is using the money to further its mission of employing AI to help match existing treatments to new diseases. The company's focus stems from the personal experience of one of its founders, David Fajgenbaum, an immunologist and associate professor at University of Pennsylvania, who credits a repurposed drug with saving his life.
Late Tuesday night, Carequality released new information about its investigation into the dispute between electronic health records vendor Epic Systems and health data startup Particle Health that has now escalated into an antitrust lawsuit.